Burning mouth syndrome: updates on pathogenesis and diagnostic algorithms

Burning Mouth Syndrome (BMS) is a complex, chronic neuropathic orofacial pain disorder characterized by a persistent burning or dysesthetic sensation in the oral cavity without an identifiable organic cause. Accurate diagnosis and effective management of BMS pose significant challenges to clinicians, necessitating a comprehensive and multidisciplinary approach. This review delves into BMS’s pathogenesis and diagnostic algorithms, highlighting the latest advancements in understanding the underlying mechanisms and diagnostic strategies. Utilizing specific diagnostic algorithms assists clinicians in assessing and selecting appropriate treatment strategies, thereby minimizing diagnostic delays. These algorithms are crucial for excluding other causes of oral burning by focusing on symptomatology, patient history, and clinical examination. They involve ruling out oral infections, nutritional deficiencies, hormonal imbalances, autoimmune disorders, and medication side effects as potential causative factors. Supporting the diagnostic process, additional tests such as blood tests (including a thrombophilic panel and Neuron-Specific Enolase), neurosensory assessments, neuroradiological examinations, and evaluations of psychological profiles and cognitive function may be employed. Neurosensory assessments and neuroradiological examinations can provide insights into possible neuropathic causes, while psychological and cognitive assessments can identify any psychological factors and the extent to which cognitive decline may contribute to the condition. A comprehensive diagnostic approach not only aids in the accurate identification of BMS but also helps differentiate it from other oral conditions with similar presentations. This thorough evaluation is essential for developing a tailored treatment plan that addresses each patient’s specific needs, ultimately improving clinical outcomes and enhancing the quality of life for individuals suffering from BMS.

Burning mouth syndrome; Dysesthetic sensation; Xerostomia; Anxiety; Depression; White matter change

[1] International classification of orofacial pain, 1st edition (ICOP). Cephalalgia. 2020; 40: 129–221.

[2] Fedele S, Fricchione G, Porter SR, Mignogna MD. Burning mouth syndrome (stomatodynia). QJM: An International Journal of Medicine. 2007; 100: 527–530.

[3] Sullivan PD. The diagnosis and treatment of psychogenic glossodynia. Ear, Nose & Throat Journal. 1989; 68: 795–798.

[4] Fortuna G, Di Lorenzo M, Pollio A. Complex oral sensitivity disorder: a reappraisal of current classification of burning mouth syndrome. Oral Diseases. 2013; 19: 730–732.

[5] Adamo D, Calabria E, Canfora F, Coppola N, Pecoraro G, D’Aniello L, et al. Burning mouth syndrome: analysis of diagnostic delay in 500 patients. Oral Diseases. 2024; 30: 1543–1554.

[6] Chmieliauskaite M, Stelson EA, Epstein JB, Klasser GD, Farag A, Carey B, et al. Consensus agreement to rename burning mouth syndrome and improve ICD-11 disease criteria: an international Delphi study. Pain. 2021; 162: 2548–2557.

[7] The Lancet. ICD-11. The Lancet. 2019; 393: 2275.

[8] Musella G, Canfora F, Caponio VCA, Vardas E, Kouri M, Nikitakis N, et al. Oral dysaesthetic and perceptual disorder, a distinct subset of chronic orofacial pain without burning symptoms: a case-control study. Journal of Oral Rehabilitation. 2025; 52: 651–666.

[9] Shinoda M, Kubo A, Hayashi Y, Iwata K. Peripheral and central mechanisms of persistent orofacial pain. Frontiers in Neuroscience. 2019; 13: 1227.

[10] Adamo D, Spagnuolo G. Burning mouth syndrome: an overview and future perspectives. International Journal of Environmental Research and Public Health. 2022; 20: 682.

[11] Seol SH, Chung G. Estrogen-dependent regulation of transient receptor potential vanilloid 1 (TRPV1) and P2X purinoceptor 3 (P2X3): implication in burning mouth syndrome. Journal of Dental Sciences. 2022; 17: 8–13.

[12] Egido-Moreno S, Valls-Roca-Umbert J, Perez-Sayans M, Blanco-Carrión A, Jane-Salas E, López-López J. Role of thyroid hormones in burning mouth syndrome. Systematic review. Medicina Oral, Patologia Oral, Cirugia Bucal. 2023; 28: e81–e86.

[13] Lee SJ, Kim C, Yu H, Kim DK. Relationship of depression, anxiety, and bipolar disease with burning mouth syndrome: a nationwide cohort study. International Journal of Environmental Research and Public Health. 2023; 20: 3391.

[14] Wu S, Zhang W, Yan J, Noma N, Young A, Yan Z. Worldwide prevalence estimates of burning mouth syndrome: a systematic review and meta-analysis. Oral Diseases. 2022; 28: 1431–1440.

[15] Kohorst JJ, Bruce AJ, Torgerson RR, Schenck LA, Davis MDP. The prevalence of burning mouth syndrome: a population-based study. British Journal of Dermatology. 2015; 172: 1654–1656.

[16] Klasser GD, Fischer DJ, Epstein JB. Burning mouth syndrome: recognition, understanding, and management. Oral and Maxillofacial Surgery Clinics of North America. 2008; 20: 255–271, vii.

[17] Ni Riordain R, O’Dwyer S, McCreary C. Burning mouth syndrome-a diagnostic dilemma. Irish Journal of Medical Science. 2019; 188: 731–734.

[18] Kim JY, Kim YS, Ko I, Kim DK. Association between burning mouth syndrome and the development of depression, anxiety, dementia, and Parkinson disease. JAMA Otolaryngology—Head & Neck Surgery. 2020; 146: 561–569.

[19] Kang JH, Kim YY, Chang JY, Kho HS. Relationships between oral MUC1 expression and salivary hormones in burning mouth syndrome. Archives of Oral Biology. 2017; 78: 58–64.

[20] Gu Y, Baldwin S, Canning C. Hypovitaminosis D, objective oral dryness, and fungal hyphae as three precipitating factors for a subset of secondary burning mouth syndrome. Heliyon. 2023; 9: e19954.

[21] Salort-Llorca C, Mínguez-Serra MP, Silvestre FJ. Drug-induced burning mouth syndrome: a new etiological diagnosis. Medicina Oral, Patologia Oral, Cirugia Bucal. 2008; 13: E167–E170.

[22] Iwata K, Takeda M, Oh SB, Shinoda M. Neurophysiology of orofacial pain. In CS Farah, R Balasubramaniam, MJ McCullough (eds.) Contemporary oral medicine (pp. 1–23). Springer: Cham. 2017.

[23] Kato S, Kurokawa R, Suzuki F, Amemiya S, Shinozaki T, Takanezawa D, et al. White and gray matter abnormality in burning mouth syndrome evaluated with diffusion tensor imaging and neurite orientation dispersion and density imaging. Magnetic Resonance in Medical Sciences. 2024; 23: 204–213.

[24] Sinding C, Gransjøen AM, Schlumberger G, Grushka M, Frasnelli J, Singh PB. Grey matter changes of the pain matrix in patients with burning mouth syndrome. European Journal of Neuroscience. 2016; 43: 997–1005.

[25] Lauria G, Majorana A, Borgna M, Lombardi R, Penza P, Padovani A, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain. 2005; 115: 332–337.

[26] Kolkka M, Forssell H, Virtanen A, Puhakka A, Pesonen U, Jääskeläinen SK. Neurophysiology and genetics of burning mouth syndrome. European Journal of Pain. 2019; 23: 1153–1161.

[27] Meacham K, Shepherd A, Mohapatra DP, Haroutounian S. Neuropathic pain: central vs. peripheral mechanisms. Current Pain and Headache Reports. 2017; 21: 28.

[28] Imamura Y, Ozasa K, Nishihara C, Asano S, Takanezawa D, Ikeda M, et al. Burning mouth syndrome and nociplastic pain. Japanese Journal of Oral Diagnosis/Oral Medicine. 2020; 33: 145–152. (In Japanese)

[29] Gremeau-Richard C, Pionchon P, Mulliez A, Dualé C, Dallel R. Enhanced pain facilitation rather than impaired pain inhibition in burning mouth syndrome female patients. The Journal of Headache and Pain. 2022; 23: 143.

[30] Kurokawa R, Kamiya K, Inui S, Kato S, Suzuki F, Amemiya S, et al. Structural connectivity changes in the cerebral pain matrix in burning mouth syndrome: a multi-shell, multi-tissue-constrained spherical deconvolution model analysis. Neuroradiology. 2021; 63: 2005–2012.

[31] Hagelberg N, Forssell H, Rinne JO, Scheinin H, Taiminen T, Aalto S, et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain. 2003; 101: 149–154.

[32] Wood PB. Role of central dopamine in pain and analgesia. Expert Review of Neurotherapeutics. 2008; 8: 781–797.

[33] Khan SA, Keaser ML, Meiller TF, Seminowicz DA. Altered structure and function in the hippocampus and medial prefrontal cortex in patients with burning mouth syndrome. Pain. 2014; 155: 1472–1480.

[34] Lee YC, Jahng GH, Ryu CW, Byun JY. Change in gray matter volume and cerebral blood flow in patients with burning mouth syndrome. Journal of Oral Pathology & Medicine. 2019; 48: 335–342.

[35] Ong WY, Stohler CS, Herr DR. Role of the prefrontal cortex in pain processing. Molecular Neurobiology. 2019; 56: 1137–1166.

[36] Adamo D, Canfora F, Calabria E, Coppola N, Leuci S, Pecoraro G, et al. White matter hyperintensities in burning mouth syndrome assessed according to the age-related white matter changes scale. Frontiers in Aging Neuroscience. 2022; 14: 923720.

[37] Jääskeläinen SK, Woda A. Burning mouth syndrome. Cephalalgia. 2017; 37: 627–647.

[38] Puhakka A, Forssell H, Soinila S, Virtanen A, Röyttä M, Laine M, et al. Peripheral nervous system involvement in primary burning mouth syndrome—results of a pilot study. Oral Diseases. 2016; 22: 338–344.

[39] Moura B de S, Ferreira NDR, DosSantos MF, Janini MER. Changes in the vibration sensitivity and pressure pain thresholds in patients with burning mouth syndrome. PLOS ONE. 2018; 13: e0197834.

[40] Kolkka-Palomaa M, Jääskeläinen SK, Laine MA, Teerijoki-Oksa T, Sandell M, Forssell H. Pathophysiology of primary burning mouth syndrome with special focus on taste dysfunction: a review. Oral Diseases. 2015; 21: 937–948.

[41] Kolkka M, Jääskeläinen S, Forssell H, Suominen A, Teerijoki-Oksa T, Loimaranta V, et al. Taste perception and saliva composition are not altered in burning mouth syndrome. Oral Diseases. 2025; 31: 1317–1332.

[42] Yilmaz Z, Renton T, Yiangou Y, Zakrzewska J, Chessell IP, Bountra C, et al. Burning mouth syndrome as a trigeminal small fibre neuropathy: increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. Journal of Clinical Neuroscience. 2007; 14: 864–871.

[43] Beneng K, Yilmaz Z, Yiangou Y, McParland H, Anand P, Renton T. Sensory purinergic receptor P2X3 is elevated in burning mouth syndrome. International Journal of Oral and Maxillofacial Surgery. 2010; 39: 815–819.

[44] Ishida Y, Ugawa S, Ueda T, Yamada T, Shibata Y, Hondoh A, et al. P2X2- and P2X3-positive fibers in fungiform papillae originate from the chorda tympani but not the trigeminal nerve in rats and mice. Journal of Comparative Neurology. 2009; 514: 131–144.

[45] García-Domínguez M. NGF in neuropathic pain: understanding its role and therapeutic opportunities. Current Issues in Molecular Biology. 2025; 47: 93.

[46] Heiliczer S, Yanko R, Sharav Y, Aframian DJ, Klutstein M, Wilensky A, et al. Oxidative stress-mediated proapoptosis signaling: a novel theory on the mechanism underlying the pathogenesis of burning mouth syndrome. The Journal of the American Dental Association. 2024; 155: 258–267.

[47] Kishore J, Shaikh F, Zubairi AM, Mirza S, Alqutub MN, AlMubarak AM, et al. Evaluation of serum neuron specific enolase levels among patients with primary and secondary burning mouth syndrome. Cephalalgia. 2022; 42: 119–127.

[48] Toyama M, Kudo C, Mukai C, Inoue M, Oyamaguchi A, Hanamoto H, et al. Trigeminal nervous system sensitization by infraorbital nerve injury enhances responses in a migraine model. Cephalalgia. 2017; 37: 1317–1328.

[49] Dieb W, Ouachikh O, Durif F, Hafidi A. Nigrostriatal dopaminergic depletion produces orofacial static mechanical allodynia. European Journal of Pain. 2016; 20: 196–205.

[50] Taiminen T, Kuusalo L, Lehtinen L, Forssell H, Hagelberg N, Tenovuo O, et al. Psychiatric (axis I) and personality (axis II) disorders in patients with burning mouth syndrome or atypical facial pain. Scandinavian Journal of Pain. 2011; 2: 155–160.

[51] Schiavone V, Adamo D, Ventrella G, Morlino M, De Notaris EB, Ravel MG, et al. Anxiety, depression, and pain in burning mouth syndrome: first chicken or egg? Headache. 2012; 52: 1019–1025.

[52] Canfora F, Ottaviani G, Calabria E, Pecoraro G, Leuci S, Coppola N, et al. Advancements in understanding and classifying chronic orofacial pain: key insights from biopsychosocial models and international classifications (ICHD-3, ICD-11, ICOP). Biomedicines. 2023; 11: 3266.

[53] Adamo D, Sardella A, Varoni E, Lajolo C, Biasotto M, Ottaviani G, et al. The association between burning mouth syndrome and sleep disturbance: a case-control multicentre study. Oral Diseases. 2018; 24: 638–649.

[54] Alhendi F, Ko E, Graham L, Corby P. The association of sleep disturbances with burning mouth syndrome: an overlooked relationship—a qualitative systematic review. Oral Diseases. 2023; 29: 6–20.

[55] Tan Y, Wu X, Chen J, Kong L, Qian Z. Structural and functional connectivity between the amygdala and orbital frontal cortex in burning mouth syndrome: an fMRI study. Frontiers in Psychology. 2019; 10: 1700.

[56] Mbiydzenyuy NE, Qulu LA. Stress, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-gonadal axis, and aggression. Metabolic Brain Disease. 2024; 39: 1613–1636.

[57] Adamo D, Pecoraro G, Coppola N, Calabria E, Aria M, Mignogna M. Vortioxetine versus other antidepressants in the treatment of burning mouth syndrome: an open-label randomized trial. Oral Diseases. 2021; 27: 1022–1041.

[58] Adamo D, Pecoraro G, Aria M, Favia G, Mignogna MD. Vortioxetine in the treatment of mood disorders associated with burning mouth syndrome: results of an open-label, flexible-dose pilot study. Pain Medicine. 2020; 21: 185–194.

[59] Taheri N, Pirboveiri R, Sayyah M, Bijanzadeh M, Ghandil P. Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia. BMC Psychiatry. 2023; 23: 781.

[60] Echeverria-Villalobos M, Tortorici V, Brito BE, Ryskamp D, Uribe A, Weaver T. The role of neuroinflammation in the transition of acute to chronic pain and the opioid-induced hyperalgesia and tolerance. Frontiers in Pharmacology. 2023; 14: 1297931.

[61] Jin H, Li M, Jeong E, Castro-Martinez F, Zuker CS. A body-brain circuit that regulates body inflammatory responses. Nature. 2024; 630: 695–703.

[62] Al-Maweri SA, Javed F, Kalakonda B, AlAizari NA, Al-Soneidar W, Al-Akwa A. Efficacy of low level laser therapy in the treatment of burning mouth syndrome: a systematic review. Photodiagnosis and Photodynamic Therapy. 2017; 17: 188–193.

[63] Moreau C, El Habnouni C, Lecron J-C, Morel F, Delwail A, Le Gall-Ianotto C, et al. Salivary metabolome indicates a shift in tyrosine metabolism in patients with burning mouth syndrome: a prospective case-control study. Pain. 2023; 164: e144–e156.

[64] Geerlings MI, Gerritsen L. Late-life depression, hippocampal volumes, and hypothalamic-pituitary-adrenal axis regulation: a systematic review and meta-analysis. Biological Psychiatry. 2017; 82: 339–350.

[65] Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychological Bulletin. 2014; 140: 774–815.

[66] Takeuchi T, Hashimoto K, Koyama A, Asakura K, Hashizume M. The association of central sensitisation with depression, anxiety, and somatic symptoms: a cross-sectional study of a mental health outpatient clinic in Japan. Life. 2024; 14: 612.

[67] Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. The Journal of Pain. 2009; 10: 895–926.

[68] Ozasa K, Noma N, Young A, Korczeniewska OA, Eliav E, Imamura Y. Potential differences in somatosensory function during premenopause and early and late postmenopause in patients with burning mouth syndrome: an observational case-control study. The Journal of Dental Sciences. 2022; 17: 399–406.

[69] Gao N, Li M, Wang W, Liu Z, Guo Y. The dual role of TRPV1 in peripheral neuropathic pain: pain switches caused by its sensitization or desensitization. Frontiers in Molecular Neuroscience. 2024; 17: 1400118.

[70] Fernández-Agra M, González-Serrano J, de Pedro M, Virto L, Caponio VCA, Ibáñez-Prieto E, et al. Salivary biomarkers in burning mouth syndrome: a systematic review and meta-analysis. Oral Diseases. 2023; 29: 2600–2613.

[71] Moisset X, Calbacho V, Torres P, Gremeau-Richard C, Dallel R. Co-occurrence of pain symptoms and somatosensory sensitivity in burning mouth syndrome: a systematic review. PLOS ONE. 2016; 11: e0163449.

[72] Galli F, Lodi G, Sardella A, Vegni E. Role of psychological factors in burning mouth syndrome: a systematic review and meta-analysis. Cephalalgia. 2017; 37: 265–277.

[73] Mignogna MD, Pollio A, Fortuna G, Leuci S, Ruoppo E, Adamo D, et al. Unexplained somatic comorbidities in patients with burning mouth syndrome: a controlled clinical study. Journal of Orofacial Pain. 2011; 25: 131–140.

[74] Leuci S, Coppola N, Adamo D, Crocetto F, Barone B, Baldares S, et al. Sexual desire, mood disorders and sleep disturbances in female BMS patients: a controlled study. Journal of Oral Pathology & Medicine. 2023; 52: 276–282.

[75] Jin J-Q, Cui H-M, Han Y, Su S, Liu H-W. Multifactor analysis of patients with oral sensory complaints in a case-control study. Chinese Medical Journal. 2020; 133: 2822–2828.

[76] Canfora F, Calabria E, Pecoraro G, Leuci S, Coppola N, Mazzaccara C, et al. Prevalence of hypertension and correlation with mental health in women with burning mouth syndrome: a case-control study. Frontiers in Cardiovascular Medicine. 2022; 9: 969148.

[77] Calabria E, Canfora F, Adamo D. Chronic orofacial pain and white matter hyperintensities. Aging (Albany NY). 2023; 15: 1708–1710.

[78] LeVasseur E, Fogel M, Khanna D. A study on the effects of hypothyroidism on the senses: a comprehensive narrative review. Cureus. 2024; 16: e65684.

[79] Morr Verenzuela CS, Davis MDP, Bruce AJ, Torgerson RR. Burning mouth syndrome: results of screening tests for vitamin and mineral deficiencies, thyroid hormone, and glucose levels-experience at Mayo Clinic over a decade. International Journal of Dermatology. 2017; 56: 952–956.

[80] Femiano F, Lanza A, Buonaiuto C, Gombos F, Nunziata M, Cuccurullo L, et al. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2008; 105: e22–e27.

[81] Li L, Wu S, Noma N, Young A, Wang X, Yan Z. Relationship between burning mouth disorder and gastroesophageal reflux disease: a scoping review. Oral Diseases. 2024; 30: 3600–3609.

[82] Aframian DJ, Ofir M, Benoliel R. Comparison of oral mucosal pH values in bulimia nervosa, GERD, BMS patients and healthy population. Oral Diseases. 2010; 16: 807–811.

[83] Becker S, Schmidt C, Berghaus A, Tschiesner U, Olzowy B, Reichel O. Does laryngopharyngeal reflux cause intraoral burning sensations? A preliminary study. European Archives of Oto-Rhino-Laryngology. 2011; 268: 1375–1381.

[84] Lechien JR, Hans S, De Marrez LG, Dequanter D, Rodriguez A, Muls V, et al. Prevalence and features of laryngopharyngeal reflux in patients with primary burning mouth syndrome. Laryngoscope. 2021; 131: E2627–E2633.

[85] Russo M, Crafa P, Franceschi M, Rodriguez-Castro KI, Franzoni L, Guglielmetti S, et al. Burning mouth syndrome and reflux disease: relationship and clinical implications. Acta Biomedica. 2022; 93: e2022329.

[86] Canfora F, Calabria E, Cuocolo R, Ugga L, Buono G, Marenzi G, et al. Burning fog: cognitive impairment in burning mouth syndrome. Frontiers in Aging Neuroscience. 2021; 13: 727417.

[87] Dugan C, Parlatescu I, Dobre M, Pîrvu RE, Milanesi E. Insights on brain functions in burning mouth syndrome. Frontiers in Systems Neuroscience. 2022; 16: 975126.

[88] Femminella GD, Canfora F, Musella G, Di Tella GS, Ugga L, Pecoraro G, et al. Cognitive profile in burning mouth syndrome versus mild cognitive impairment: a comparative study. Oral Diseases. 2025; 31: 611–632.

[89] Canfora F, Cataldi M, Mignogna MD, Ottaviani G, Leuci S, Coppola N, et al. Blueprint persona and information and communication technology interventions: addressing unmet needs in burning mouth syndrome care. Journal of Evidence-Based Dental Practice. 2025; 25: 102047.

[90] O G, Balasubramaniam R, Klasser GD. Burning mouth disorder and Parkinson’s disease: a scoping review of the literature. Journal of Oral Rehabilitation. 2023; 50: 488–500.

[91] Prakash S, Ahuja S, Rathod C. Dopa responsive burning mouth syndrome: restless mouth syndrome or oral variant of restless legs syndrome? Journal of the Neurological Sciences. 2012; 320: 156–160.

[92] Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, et al. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells. 2023; 12: 816.

[93] Mastrangelo A, Bonato M, Cinque P. Smell and taste disorders in COVID-19: from pathogenesis to clinical features and outcomes. Neuroscience Letters. 2021; 748: 135694.

[94] The Lancet Psychiatry. COVID-19 and mental health. The Lancet Psychiatry. 2021; 8: 87.

[95] Candela CF, Pia LJ, Pons-Fuster E, Tvarijonaviciute A. Impact of the COVID-19 pandemic upon patients with burning mouth syndrome. Journal of Stomatology Oral and Maxillofacial Surgery. 2022; 123: 101–104.

[96] Ottaviani G, Canfora F, Leuci S, Coppola N, Pecoraro G, Rupel K, et al. COVID-19 impact on post-traumatic stress symptoms in burning mouth syndrome: a multicentric study. Oral Diseases. 2024; 30: 4653–4667.

[97] Gobel H. The international classification of headache disorders 3rd edition. 2018. Available at: https://ichd-3.org/ (Accessed: 09 February 2022).

[98] Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013; 33: 629–808.

[99] Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: classification and criteria changes. World Psychiatry. 2013; 12: 92–98.

[100] Obara T, Naito H, Nojima T, Koga H, Nakao A. Burning mouth syndrome induced by angiotensin-converting enzyme inhibitors. Cureus. 2020; 12: e11376.

[101] Borrás-Blasco J, Belda A, Rosique-Robles JD, Castera ME, Abad FJ. Burning mouth syndrome due to efavirenz therapy. Annals of Pharmacotherapy. 2006; 40: 1471–1472.

[102] Yang G, Jin J, Wang K, Baad-Hansen L, Liu H, Cao Y, et al. Conditioned pain modulation differences in central and peripheral burning mouth syndrome (BMS) patients. Journal of Oral Rehabilitation. 2025; 52: 443–452.

[103] Wu YH, Jin YT, Wu YC, Yu-Fong Chang J, Chiang CP, Sun A. Anemia, hematinic deficiencies, and hyperhomocysteinemia in male and female burning mouth syndrome patients. The Journal of Dental Sciences. 2022; 17: 935–941.

[104] Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutrition Journal. 2015; 14: 6.

[105] Gaifullina AS, Lazniewska J, Gerasimova EV, Burkhanova GF, Rzhepetskyy Y, Tomin A, et al. A potential role for T-type calcium channels in homocysteinemia-induced peripheral neuropathy. Pain. 2019; 160: 2798–2810.

[106] Gerasimova E, Burkhanova G, Chernova K, Zakharov A, Enikeev D, Khaertdinov N, et al. Hyperhomocysteinemia increases susceptibility to cortical spreading depression associated with photophobia, mechanical allodynia, and anxiety in rats. Behavioural Brain Research. 2021; 409: 113324.

[107] Hainsworth AH, Yeo NE, Weekman EM, Wilcock DM. Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID). Biochimica et Biophysica Acta. 2016; 1862: 1008–1017.

[108] Page A, Aktas MK, Soyata T, Zareba W, Couderc JP. “QT clock” to improve detection of QT prolongation in long QT syndrome patients. Heart Rhythm. 2016; 13: 190–198.

[109] Nagamine T, Watanabe T, Toyofuku A. QTc shortening on electrocardiogram with amitriptyline may indicate no effect on pain relief in burning mouth syndrome. Clinical Neuropharmacology. 2024; 47: 33–36.

[110] Chen CC, Lin C, Lee DJ, Lin CS, Chen SJ, Sung CC, et al. Monitoring serum potassium concentration in patients with severe hyperkalemia: the role of bloodless artificial intelligence-enabled electrocardiography. Clinical Kidney Journal. 2025; 18: sfaf092.

[111] Suga T, Takenoshita M, Tu TTH, Sugawara T, Kirimura S, Toyofuku A. A case of vestibular schwannoma mimicking burning mouth syndrome. BioPsychoSocial Medicine. 2021; 15: 7.

[112] Liu YF, Kim Y, Yoo T, Han P, Inman JC. Burning mouth syndrome: a systematic review of treatments. Oral Diseases. 2018; 24: 325–334.

[113] Veenbergen S, Kozmar A, van Daele PLA, Schreurs MWJ. Autoantibodies in Sjögren’s syndrome and its classification criteria. Journal of Translational Autoimmunity. 2022; 5: 100138.

[114] Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American college of rheumatology/European league against rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis & Rheumatology. 2017; 69: 35–45.

[115] Farag AM, Albuquerque R, Ariyawardana A, Chmieliauskaite M, Forssell H, Nasri-Heir C, et al. World workshop in oral medicine VII: reporting of IMMPACT-recommended outcome domains in randomized controlled trials of burning mouth syndrome: a systematic review. Oral Diseases. 2019; 25: 122–140.